Holen Sie sich die Stockscreener-App
0.551
0.18%
0.001
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
62.21%
1.3761
|
0.8483 | 1.0419 | 0.9603 | 1.1061 |
| Operating Income/Loss |
62.21%
-1.3761
|
-0.8483 | -1.0419 | -0.9603 | -1.1061 |
| Nonoperating Income/Loss |
19.57%
-6.0419
|
-7.5118 | 12.79 | -2.0851 | -0.3635 |
| Income/Loss From Continuing Operations Before Tax |
11.27%
-7.418
|
-8.3601 | 11.75 | -6.0907 | -1.4696 |
| Income/Loss From Continuing Operations After Tax |
11.27%
-7.418
|
-8.3601 | 11.75 | -6.0907 | -1.4696 |
|
Net Income/Loss
|
11.27%
-7.418
|
-8.3601 | 11.75 | -6.0907 | -1.4696 |
| Preferred Stock Dividends And Other Adjustments |
0.9986
|
- | 2.9708 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | -3.0453 | -2.9589 |
| Basic Average Shares |
0.00%
6.7958
|
6.7958 | -0.1582 | 6.96 | 7.637 |
| Diluted Average Shares |
0.00%
6.7958
|
6.7958 | -0.1582 | 6.96 | 7.637 |
| Basic Earnings Per Share |
0.81%
-1.24
|
-1.23 | 1.52 | -0.44 | -0.39 |
| Diluted Earnings Per Share |
0.81%
-1.24
|
-1.23 | 1.52 | -0.44 | -0.39 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
0.68%
-8.4166
|
-8.3601 | 10.85 | -1.7031 | -0.7388 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-7.418
|
- | 13.82 | - | - |
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):